ATP8A2-CRYL1 Fusion FISH Probe
The ATP8A2-CRYL1 Fusion FISH Probe is used to confirm a fusion of the ATP8A2 and CRYL1 genes. The fusion of the ATP8A2 and CRYL1 genes has been associated with Ovarian Serous Cystadenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ATP8A2-CRYL1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ATP8A2-CRYL1-20-AQAQ | 20 (40 μL) | 200 μL |
|
CRYL1 Gene Summary
The uronate cycle functions as an alternative glucose metabolic pathway, accounting for about 5% of daily glucose catabolism. The product of this gene catalyzes the dehydrogenation of L-gulonate into dehydro-L-gulonate in the uronate cycle. The enzyme requires NAD(H) as a coenzyme, and is inhibited by inorganic phosphate. A similar gene in the rabbit is thought to serve a structural role in the lens of the eye. [provided by RefSeq, Jul 2008]
Gene Name: Crystallin Lambda 1
Chromosome: CHR13: 20977805 -21100012
Locus: 13q12.11
ATP8A2 Gene Summary
The protein encoded by this gene is a member of the P4 ATPase family of proteins, which are thought to be involved in a process called lipid flipping, whereby phospholipids are translocated inwards from the exoplasmic leaflet to the cytosolic leaflet of the cell membrane, which aids in generating and maintaining asymmetry in membrane lipids. This protein is predicted to contain an E1 E2 ATPase, a haloacid dehalogenase-like hydrolase (HAD) domain, and multiple transmembrane domains. Associations between this protein and cell cycle control protein 50A are important for translocation of phosphatidylserine across membranes. Mutations in this gene have been associated with a syndrome (CAMRQ4) characterized by cerebellar ataxia and cognitive disabilities. In addition, a translocation breakpoint within this gene was observed in an individual with neurological dysfunction. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]
Gene Name: ATPase Phospholipid Transporting 8A2
Chromosome: CHR13: 25946208 -26595420
Locus: 13q12.13
Gene Diseases
The ATP8A2 CRYL1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Ovarian Serous Cystadenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|